| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX009 (ip) | median survival time | other | 25.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 50.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | other | 100.0 mg/kg/injection | 116.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 12.5 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 25.0 mg/kg/injection | 122.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 50.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX017 (ip) | median survival time | other | 100.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 54; 08/08 animals surviving on tox evaluation day (usually day 5) |